Patriot Financial Group Insurance Agency’s Beam Therapeutics BEAM Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-285	Closed	-$11K	–	549
2022 Q2	$11K	Buy	285 +35	+14%	+$1.39K	﹤0.01%	1194
2022 Q1	$14K	Hold	250	–	–	﹤0.01%	1224
2021 Q4	$20K	Hold	250	–	–	﹤0.01%	1216
2021 Q3	$22K	Hold	250	–	–	﹤0.01%	1168
2021 Q2	$32K	Hold	250	–	–	0.01%	993
2021 Q1	$20K	Hold	250	–	–	﹤0.01%	1078
2020 Q4	$20K	Hold	250	–	–	0.01%	957
2020 Q3	$6K	Buy	+250	New	+$6.2K	﹤0.01%	1172

Other funds holding BEAM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patriot Financial Group Insurance Agency's BEAM Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Beam Therapeutics (BEAM) in Q3 2022, closing a stake of 285 shares — an estimated $11K sold.

Patriot Financial Group Insurance Agency first reported a position in BEAM in Q3 2020 and held it in 8 quarters. The position peaked at $32K in Q2 2021. 224 funds tracked by Wall St. Rank hold BEAM as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Beam Therapeutics position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 285 Beam Therapeutics shares in Q3 2022, an estimated $11K.
Patriot Financial Group Insurance Agency first reported a position in Beam Therapeutics in Q3 2020 and held it in 8 quarters.
Patriot Financial Group Insurance Agency's Beam Therapeutics position peaked at $32K in Q2 2021.
224 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.